RxSight, Inc.

NASDAQ:RXST

Medical - Devices

Healthcare
$5.01 +0.98%

+$0.05 today

Market cap
$210.07M
Beta
1.13
P/E (TTM)
-4.1
EPS (TTM)
-$1.13
52W Low $4.48High $14.29

Volume 0.74M

Average 0.80M

RXST Income Before Tax

Profit after all operating and non-operating items but before income tax.

RxSight, Inc.NASDAQ: RXST

Income Before Tax · Q1 FY2026 · quarter ended Mar 2026

Income before tax remains negative

Q1 FY2026 income before tax was -$15.88M, compared with -$8.17M a year earlier. Trailing-twelve-month income before tax was -$46.58M.

Context

  • Income before tax amounted to 28.9% of revenue in FY2025, up 9.3 pp from a year earlier.
  • Income before tax grew in size in 1 of the last 3 fiscal years.

What to watch

Whether quarterly income before tax holds near -$15.88M or moves back toward the trailing-twelve-month quarterly average of -$11.65M.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$15.88M-73.6% QoQ
Last fiscal yearDec 2025
-$38.88M-41.9% YoY
LTMMar 2026
-$46.58M-75.9% YoY
Income Before Tax past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-94.3%——
1 year-41.9%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Income Before Tax history

USD · from the income statement

Latest · FY2025
(38.88M) USD
Year-over-year change
-41.9%

Income Before Tax vs competitors

How RXST compares with its peers on the latest reported figures

  • RXST's LTM Mar 2026 income before tax of -$46.58M is the 7th highest of the 9 companies compared; the peer median is -$28.32M.
  • Its year-over-year change of -75.9% is the lowest of 9, against a peer median of +9.5%.
  • Income before tax amounts to 36.5% of revenue for RXST, versus a peer median of 16.3%.
RXST Competitors Peer median
Income Before Tax for RXST and competitors
Company Period LTM YoY 3-year CAGR% of revenue
TCMDTactile Systems Technology, Inc.LTM Mar 2026$34.51M +55.3%—10.0%
DCTHDelcath Systems, Inc.LTM Mar 2026$1.34M +109.5%—1.5%
CERSCerus CorporationLTM Mar 2026-$9.2M +51.0%—4.1%
NPCENeuroPace, Inc.LTM Mar 2026-$21.57M +13.1%—21.7%
DMACDiaMedica Therapeutics Inc.LTM Mar 2026-$35.07M -30.0%——
KIDSOrthoPediatrics Corp.LTM Mar 2026-$39.58M +5.9%—16.3%
RXSTRxSight, Inc.LTM Mar 2026-$46.58M -75.9%—36.5%
TMCITreace Medical Concepts, Inc.LTM Mar 2026-$61.04M -15.2%—29.4%
BFLYButterfly Network, Inc.LTM Mar 2026-$75.67M -16.9%—73.5%
Peer median (excluding RXST) -$28.32M+9.5%—16.3%

Competitors are the stored peer set for RXST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue22.59M49.01M89.08M139.93M134.48M
Cost of Revenue18.08M27.68M35.31M40.98M31.47M
Gross Profit4.52M21.33M53.77M98.94M103.01M
Gross Margin20.0%43.5%60.4%70.7%76.6%
Research & Development24.5M25.98M29.05M34.37M38.55M
Selling, General & Admin32.81M58.67M74.8M101.43M112.65M
Operating Expenses57.3M84.65M103.85M135.8M151.2M
Depreciation & Amortization3.99M4.02M4.24M3.62M0
EBITDA(41.01M)(57.78M)(41.04M)(23.76M)(38.84M)
EBITDA Margin-181.5%-117.9%-46.1%-17.0%-28.9%
Operating Income(52.79M)(63.32M)(50.09M)(36.86M)(48.19M)
Operating Margin-233.6%-129.2%-56.2%-26.3%-35.8%
Interest Income54K1.52M6.57M9.47M2.51M
Interest Expense3.68M4.95M3.31M21K40K
Other Income / Expenses4.11M(3.43M)1.5M9.45M9.31M
Income Before Tax(48.68M)(66.75M)(48.59M)(27.41M)(38.88M)
Pre-Tax Margin-215.5%-136.2%-54.5%-19.6%-28.9%
Income Tax Expense8K9K20K50K66K
Net Income(48.69M)(66.76M)(48.61M)(27.46M)(38.94M)
Net Margin-215.5%-136.2%-54.6%-19.6%-29.0%
EPS (Basic)(1.78)(2.41)(1.41)(0.71)(0.95)
EPS (Diluted)(1.78)(2.41)(1.41)(0.71)(0.95)
Weighted Avg Shares27.37M27.66M34.46M38.87M41.18M
Weighted Avg Shares (Diluted)27.37M27.66M34.46M38.87M41.18M

RxSight, Inc.

NASDAQ:RXST

Intrinsic Alpha fair value

Locked

Current Price

$5.01

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.